These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1324436)

  • 1. Prediction of the structure of a receptor-protein complex using a binary docking method.
    Stoddard BL; Koshland DE
    Nature; 1992 Aug; 358(6389):774-6. PubMed ID: 1324436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Template-based docking of a prolactin receptor proline-rich motif octapeptide to FKBP12: implications for cytokine receptor signaling.
    Soman KV; Hanks BA; Tien H; Chari MV; O'Neal KD; Morrisett JD
    Protein Sci; 1997 May; 6(5):999-1008. PubMed ID: 9144770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refined structures of the ligand-binding domain of the aspartate receptor from Salmonella typhimurium.
    Scott WG; Milligan DL; Milburn MV; Privé GG; Yeh J; Koshland DE; Kim SH
    J Mol Biol; 1993 Jul; 232(2):555-73. PubMed ID: 8345523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docking of small ligands to low-resolution and theoretically predicted receptor structures.
    Wojciechowski M; Skolnick J
    J Comput Chem; 2002 Jan; 23(1):189-97. PubMed ID: 11913386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein flexibility in ligand docking and virtual screening to protein kinases.
    Cavasotto CN; Abagyan RA
    J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide binding in OppA, the crystal structures of the periplasmic oligopeptide binding protein in the unliganded form and in complex with lysyllysine.
    Sleigh SH; Tame JR; Dodson EJ; Wilkinson AJ
    Biochemistry; 1997 Aug; 36(32):9747-58. PubMed ID: 9245406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural model and ligand interactions of the Xanthomonas axonopodis pv. citri oligopeptide-binding protein.
    Moutran A; Balan A; Ferreira LC; Giorgetti A; Tramontano A; Ferreira RC
    Genet Mol Res; 2007 Dec; 6(4):1169-77. PubMed ID: 18273810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for oligosaccharide recognition by Pyrococcus furiosus maltodextrin-binding protein.
    Evdokimov AG; Anderson DE; Routzahn KM; Waugh DS
    J Mol Biol; 2001 Jan; 305(4):891-904. PubMed ID: 11162100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural consensus in ligand-protein docking identifies recognition peptide motifs that bind streptavidin.
    Shah NK; Rejto PA; Verkhivker GM
    Proteins; 1997 Jul; 28(3):421-33. PubMed ID: 9223187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization by NMR and molecular modeling of the binding of polyisoprenols and polyisoprenyl recognition sequence peptides: 3D structure of the complexes reveals sites of specific interactions.
    Zhou GP; Troy FA
    Glycobiology; 2003 Feb; 13(2):51-71. PubMed ID: 12626407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDS: flexible ligand and receptor docking with a continuum solvent model and soft-core energy function.
    Taylor RD; Jewsbury PJ; Essex JW
    J Comput Chem; 2003 Oct; 24(13):1637-56. PubMed ID: 12926007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting ligand-binding function in families of bacterial receptors.
    Johnson JM; Church GM
    Proc Natl Acad Sci U S A; 2000 Apr; 97(8):3965-70. PubMed ID: 10737762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
    Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
    Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fast method to predict protein interaction sites from sequences.
    Gallet X; Charloteaux B; Thomas A; Brasseur R
    J Mol Biol; 2000 Sep; 302(4):917-26. PubMed ID: 10993732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A large-scale computational approach to drug repositioning.
    Li YY; An J; Jones SJ
    Genome Inform; 2006; 17(2):239-47. PubMed ID: 17503396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of affinity peptide ligand by flexible docking simulation.
    Liu FF; Wang T; Dong XY; Sun Y
    J Chromatogr A; 2007 Mar; 1146(1):41-50. PubMed ID: 17298835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.
    Ploug M
    Biochemistry; 1998 Nov; 37(47):16494-505. PubMed ID: 9843416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonequilibrium, multiple-timescale simulations of ligand-receptor interactions in structured protein systems.
    Zhang Y; Peters MH; Li Y
    Proteins; 2003 Aug; 52(3):339-48. PubMed ID: 12866048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Position-specific incorporation of fluorescent non-natural amino acids into maltose-binding protein for detection of ligand binding by FRET and fluorescence quenching.
    Iijima I; Hohsaka T
    Chembiochem; 2009 Apr; 10(6):999-1006. PubMed ID: 19301314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase.
    Frembgen-Kesner T; Elcock AH
    J Mol Biol; 2006 May; 359(1):202-14. PubMed ID: 16616932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.